Prof Ifeoma Okoye
Why Nigeria should tap into $24.8trn clinical trial market, by Ifeoma Okoye
A cancer expert and radiologist at the University of Nigeria Teaching Hospital (UNTH) Enugu, Prof. Ifeoma Okoye, has given reasons why Nigeria should urgently tap into the $68.9 billion (N24.8 trillion) clinical trial market. Okoye, who is also the pioneer director of the University of Nigeria Centre for Clinical Trials (UNNCECT), told The Guardian: “It…
High cost of few cancer screening, treatment centres reduces patients’ survival chances
Mrs Nwabufo Chika, (fondly nicknamed ‘Ika’) has been a breast cancer survivor for six years. Unfortunately, last year November, the cancer spread to her spine.... and affected her walking.
Concerns as blacks are disproportionately affected by cancer
Worried that blacks are disproportionately affected by cancer globally, the inaugural Global Congress on Oncology Clinical Trials in Blacks is scheduled for November 13 - November 15, 2018 at the Sheraton hotel, Ikeja Lagos. According to previous studies, Black men are 60 per cent more likely to have prostate cancer than Caucasian men, and more…